Public-registry site landscape for NCT04830124, a Cutaneous Melanoma study sponsored by Mural Oncology, Inc. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04830124 (registry record) |
| Sponsor | Mural Oncology, Inc |
| Condition(s) | Cutaneous Melanoma; Mucosal Melanoma |
| Phase | PHASE2 |
| Listed sites | 41 |
| Site countries | United States, Australia, Canada, Italy, South Korea, Spain, Taiwan, United Kingdom |
Eichor generates a preliminary site-risk snapshot for NCT04830124 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →